[Federal Register Volume 84, Number 156 (Tuesday, August 13, 2019)]
[Notices]
[Page 40106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17267]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
September 10-11, 2019. A sample of agenda items to be discussed during
the public session includes: (1) An update on medical-related events;
(2) a discussion of the ACMUI's recommendations and comments on the
draft Xcision[supreg] GammaPod Licensing Guidance; (3) a discussion on
the status of emerging technologies licensed under Title 10 Code of
Federal Regulations (10 CFR) Part 35.1000; (4) a discussion of the
ACMUI's recommendations related to the appropriateness of the required
medical event reporting in accordance with 10 CFR 35.3045; (5) a
presentation from the National Nuclear Security Administration on their
initiative to reduce the use of radioactive materials; (6) a discussion
of the ACMUI's recommendations for improving the ACMUI's institutional
memory; (7) a discussion of the ACMUI's recommendations and comments
regarding the NRC's policy decision related to infiltrations and
medical event reporting; (8) an update on the NRC staff's evaluation of
training and experience requirements for radiopharmaceuticals requiring
a written directive; and (9) a discussion on the U.S. Pharmacopeia
General Chapter <825>. The agenda is subject to change. The current
agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html or by emailing Ms. Kellee
Jamerson at the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: September 10, 2019, from 8:30 a.m.
to 2:45 p.m. and September 11, 2019, from 8:30 a.m. to 11:30 a.m.
Eastern Standard Time (EST).
Date and Time for Closed Session: September 10, 2019, from 7:30
a.m. to 8:30 a.m. and 2:45 p.m. to 5:00 p.m. EST. These sessions will
be closed on September 10, 2019, for badging and enrollment of new
members to the ACMUI and for required annual training, respectively.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T-2D30, 11545 Rockville Pike,
Rockville, Maryland 20852.
Public Participation: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Jamerson using the information below. The meeting will also be webcast
live at https://video.nrc.gov/.
Contact Information: Ms. Kellee Jamerson, email:
[email protected], telephone: (301) 415-7408.
Conduct of the Meeting
Christopher J. Palestro, M.D. will chair the meeting. Dr. Palestro
will conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson using the contact information listed
above. All submittals must be received by September 5, 2019, three
business days before the meeting, and must pertain to the topics on the
agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about October 25, 2019.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 8th day of August 2019.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-17267 Filed 8-12-19; 8:45 am]
BILLING CODE 7590-01-P